JTCS Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schreinemakers, H. H.
Right arrow Articles by Lacquet, L. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schreinemakers, H. H.
Right arrow Articles by Lacquet, L. K.

The Journal of Thoracic and Cardiovascular Surgery, Vol 95, 298-302, Copyright © 1988 by The American Association for Thoracic Surgery and The Western Thoracic Surgical Association


ARTICLES

Parasternal mediastinoscopy. Assessment of operability in left upper lobe lung cancer: a prospective analysis

HH Schreinemakers, HJ Joosten, M Mravunac and LK Lacquet
Department of Thoracic, Cardiac, and Vascular Surgery, Radboud University Hospital, Nijmegen, The Netherlands.

Between 1976 and 1984, 242 patients with presumably operable lung cancer were treated surgically. In the Canisius Wilhelmina Hospital, Nijmegen, The Netherlands, in the period 1976 to 1980, 109 of 131 (83.2%) patients underwent cervical mediastinoscopy to assess operability. They were studied retrospectively. During this examination, lymph node metastasis was demonstrated in three of 19 (15.8%) patients with left upper lobe lung cancer. At thoracotomy after a normal cervical mediastinoscopic study or no mediastinoscopic study, periaortic lymph node metastases were found in eight of 34 (23.5%) patients with left upper lobe lung cancer. In the period 1981 to 1984, the value of left parasternal mediastinoscopy was studied prospectively in patients with left lung cancer in the Canisius Wilhelmina Hospital, Nijmegen; in the Lung Centre of the Radboud University Hospital, Nijmegen; and in the Lung Center of the Dekkerswald Medical Centre, Groesbeek. Cervical or cervical and parasternal mediastinoscopy were performed in 69 of 111 (62.2%) patients. At parasternal mediastinoscopy performed after a normal cervical mediastinoscopic study, periaortic lymph node metastases were found in seven of 31 (22.6%) patients with left upper lobe lung cancer. All periaortic lymph node metastases showed intranodal and extranodal growth. The resectability rate in left upper lobe lung cancer was 79.4% in the retrospective group and 96.5% in the prospective group. There were no serious complications after parasternal mediastinoscopy. These data point to the reliability of parasternal mediastinoscopy in the assessment of left upper lobe lung cancer. The study provides essential information for the staging and treatment of non-small cell lung cancer of the left upper lobe.


This article has been cited by other articles:


Home page
Eur Respir JHome page
J. Deslauriers
Current surgical treatment of nonsmall cell lung cancer 2001
Eur. Respir. J., February 1, 2002; 19(35_suppl): 61S - 70s.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
J. Mouroux, N. Venissac, and M. Alifano
Combined video-assisted mediastinoscopy and video-assisted thoracoscopy in the management of lung cancer
Ann. Thorac. Surg., November 1, 2001; 72(5): 1698 - 1704.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
J. Deslauriers and J. Gregoire
Clinical and Surgical Staging of Non-Small Cell Lung Cancer
Chest, April 1, 2000; 117(4_suppl_1): 96S - 103S.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1988 by The American Association for Thoracic Surgery.